Valuation : Boule Diagnostics AB

Market Cap 123M 12.84M 11.07M 10.38M 9.47M 17.84M 1.23B 17.9M 48.03M 620M 48.22M 47.17M 2.05B P/E 2026 *
-12.6x
P/E 2027 * 14.3x
Enterprise Value 320M 33.35M 28.74M 26.94M 24.59M 46.33M 3.19B 46.48M 125M 1.61B 125M 122M 5.33B EV / Sales 2026 *
0.71x
EV / Sales 2027 * 0.64x
Free-Float
53.64%
Yield 2026 *
-
Yield 2027 * -
1 day+1.60%
1 week-2.46%
Current month-17.02%
1 month-12.91%
3 months-4.52%
6 months-26.28%
Current year-35.44%
1 week 3.1
Extreme 3.1
3.28
1 month 3.1
Extreme 3.1
3.95
Current year 2.75
Extreme 2.75
5.68
1 year 2.75
Extreme 2.75
6.64
3 years 2.75
Extreme 2.75
12.62
5 years 2.75
Extreme 2.75
59.5
10 years 2.75
Extreme 2.75
108.88
Manager TitleAgeSince
Chief Executive Officer - 22/06/2026
Director of Finance/CFO 54 11/02/2026
Chief Tech/Sci/R&D Officer - 01/01/2019
Director TitleAgeSince
Director/Board Member 59 01/01/2014
Chairman 73 01/01/2021
Chairman 74 01/01/2023
Date Insider Type Main position Quantity % Market Cap.
27/02/23 Buy

Chief Financial Officer

8,000 0.0206%
06/02/23 Buy

Director

7,083 0.0182%
17/02/22 Buy

Director

2,000 0.0103%
Change 5-day change 1-year change 3-year change Capi.($)
+1.60%-2.46%-49.20%-66.46% 12.84M
-1.35%-1.13%+26.27%+12.02% 230B
+0.18%-1.27%+4.98%-18.16% 152B
+1.51%-1.64%-21.28%+20.04% 132B
+0.36%-7.01%-55.60%-14.34% 67.88B
+0.29%+0.47%+10.90%+15.91% 52B
+0.66%-1.69%-16.47%-14.35% 51.05B
-2.44%-3.25%+22.43%+26.08% 43.38B
-1.56%+0.97%+37.41%+44.08% 40.74B
+1.94%+3.81%-12.45%+46.61% 34.67B
Average +0.12%-1.00%-5.30%+5.14% 80.33B
Weighted average by Cap. -0.14%-1.29%+2.51%+7.85%

Financials

2026 *2027 *
Net sales 453M 47.27M 40.73M 38.19M 34.86M 65.68M 4.52B 65.89M 177M 2.28B 177M 174M 7.56B 483M 50.42M 43.45M 40.74M 37.19M 70.06M 4.82B 70.28M 189M 2.43B 189M 185M 8.07B
Net income -9.77M -1.02M -879K -824K -752K -1.42M -97.45M -1.42M -3.81M -49.19M -3.83M -3.74M -163M 8.6M 897K 773K 725K 661K 1.25M 85.71M 1.25M 3.35M 43.27M 3.37M 3.29M 143M
Net Debt 197M 20.5M 17.67M 16.57M 15.12M 28.49M 1.96B 28.58M 76.68M 989M 76.98M 75.31M 3.28B 185M 19.25M 16.59M 15.55M 14.2M 26.75M 1.84B 26.83M 71.99M 929M 72.27M 70.7M 3.08B
Logo Boule Diagnostics AB
Boule Diagnostics AB is a Sweden-based company engaged in the provision of medical diagnostic and testing equipment. The Company specializes in the development, manufacture and sale of complete blood count (CBC) systems in the field of hematology. It provides reagents, cleaning products and blood calibrators and controls that are used in human and veterinarian laboratories, as well as analyzers and complementing accessories for hematology systems. The Company’s product portfolio comprises five brands: Clinical Diagnostic Solutions, Exigo, Medonic, Swelab and Quintus. The Company’s primary customer base comprises small and medium-sized hospitals, clinics, diagnostics firms and laboratories. Furthermore, It operates worldwide through a number of subsidiaries, such as Boule Medical AB, Boule Nordic AB, Clinical Diagnostic Solutions Inc and Boule Medical (Beijing) Co Ltd.
Employees
200
Date Price Change Volume
28/08/26 SEK 3.170 +1.60% 32,422
27/08/26 SEK 3.120 -0.32% 27,493
26/08/26 SEK 3.130 -1.88% 36,335
25/08/26 SEK 3.190 -0.62% 54,722
24/08/26 SEK 3.210 -1.23% 11,704
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
3.170SEK
Average target price
3.800SEK
Spread / Average Target
+19.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BOUL Stock